Bharat Parenterals Limited Stock Price Today (NSE: BPLPHARMA)
Fundamental Score
Bharat Parenterals Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Bharat Parenterals Limited share price today is ₹1534.00, up +0.00% on NSE/BSE as of 18 September 2026. Bharat Parenterals Limited (BPLPHARMA) is a Small-cap company in the Unknown Industry sector with a market capitalisation of ₹0.00 (Cr). The 52-week high for BPLPHARMA share price is ₹1649.00 and the 52-week low is ₹1125.70.
Bharat Parenterals Limited Share Price Chart — NSE/BSE Historical Performance
Bharat Parenterals Limited share price chart: 19.25% return over the past month. 52-week high ₹1649.00, 52-week low ₹1125.70.
Bharat Parenterals Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹1549.20 | ₹1549.20 | ₹1504.90 | ₹1534.00 | 32.00 (Cr) | |
| ₹1570.00 | ₹1570.00 | ₹1500.00 | ₹1509.80 | 515.00 (Cr) | |
| ₹1575.00 | ₹1575.00 | ₹1510.00 | ₹1543.40 | 2.21K (Cr) | |
| ₹1558.60 | ₹1577.00 | ₹1449.80 | ₹1505.10 | 8.42K (Cr) | |
| ₹1565.00 | ₹1565.00 | ₹1530.00 | ₹1558.60 | 1.27K (Cr) | |
| ₹1570.00 | ₹1582.50 | ₹1500.00 | ₹1518.60 | 1.69K (Cr) | |
| ₹1575.00 | ₹1575.00 | ₹1548.00 | ₹1568.80 | 939.00 (Cr) | |
| ₹1539.00 | ₹1575.00 | ₹1500.00 | ₹1548.70 | 1.03K (Cr) | |
| ₹1545.00 | ₹1568.80 | ₹1520.00 | ₹1533.30 | 586.00 (Cr) | |
| ₹1568.30 | ₹1568.30 | ₹1512.40 | ₹1520.80 | 897.00 (Cr) |
Bharat Parenterals Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹1565.00 | ₹1585.80 | ₹1449.80 | ₹1534.00 | -1.98% | |
| ₹1400.00 | ₹1649.00 | ₹1125.70 | ₹1529.80 | +9.27% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Bharat Parenterals Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bharat Parenterals Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BPLPHARMA across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Healthy Liquidity Position (Current Ratio: 1.62)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Risk Factors
0 factors identified
No significant concerns identified in current analysis.
Bharat Parenterals Limited vs Sector Peers
Bharat Parenterals Limited PE Ratio History
Historical price-to-earnings ratio for BPLPHARMA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹24.94 | ₹1467.75 | 58.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Bharat Parenterals Limited Dividend History
Annual cash dividends paid by BPLPHARMA — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹0.58 Cr |
| FY 2024 | ₹0.43 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Bharat Parenterals Limited Quarterly Performance
Latest quarterly metrics for BPLPHARMA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Bharat Parenterals Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for BPLPHARMA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Bharat Parenterals Limited Financial Statements
Annual income statement, balance sheet and cash flow for Bharat Parenterals Limited (BPLPHARMA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Bharat Parenterals Limited
About BPLPHARMA (Bharat Parenterals Limited)
Bharat Parenterals Limited (BPLPHARMA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Unknown Industry sector ...with a current market capitalisation of ₹0.00 (Cr). Investors tracking BPLPHARMA share price can monitor key metrics including P/E ratio, promoter holding of N/A%, and quarterly earnings growth.
Company Details
BPLPHARMA Share Price: Frequently Asked Questions
What is the current share price of Bharat Parenterals Limited?
Bharat Parenterals Limited (BPLPHARMA) trades at ₹1534.00 on NSE. Market cap ₹N/A. Educational data only.
What is the P/E ratio of Bharat Parenterals Limited?
Bharat Parenterals Limited has a P/E of N/Ax vs industry average N/Ax.
What is the Bull Run score for Bharat Parenterals Limited?
Bharat Parenterals Limited has a Bull Run score of 0/100 based on 25+ financial parameters.
Does Bharat Parenterals Limited pay dividends?
Bharat Parenterals Limited has a dividend yield of N/A. Past dividends don't guarantee future payments.
What is the ROE of Bharat Parenterals Limited?
Bharat Parenterals Limited has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Bharat Parenterals Limited?
Bharat Parenterals Limited has debt-to-equity of N/A.
Is Bharat Parenterals Limited a good investment?
Bull Run gives Bharat Parenterals Limited a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.